Real-world experiences of dyslipidaemia in patients with high or very high cardiovascular risk.
Event:
ESC Congress 2022
Topic:
Lipid-Lowering Agents
Session:
Real-world experiences of dyslipidaemia in patients with high or very high cardiovascular risk